NUEVAS ALTERNATIVAS NATURALES THERMAFAT; S.A.P.I. DE C.V.
发明人:
GABRIEL GOJON ROMANILLOS
申请号：
BR112015017440
公开号：
BR112015017440A2
申请日:
2014.01.28
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
compositions for systemic treatment of pathological conditions resulting from oxidative stress and / or redox imbalance abstract alterations of redox homeostasis in mammals underlie a host of symptoms, syndromes and diseases, including aids and cancer, which can be successfully treated by administration to a mammal of therapeutically -effective amounts of sulfide compounds and / or thiosulfate compounds and / or thionite compounds and / or thionate compounds and / or any chemical species capable of providing a subject in need thereof sulfide compound, thiosulfate compound, thionite compound, or thionate compound. the unique compositions of this invention contain one or more "active sulfur substances" in combination with each other or with other therapeutic agents. the invention also encompasses the varying modes of administration of the therapeutic substances. in particular, a novel method of combining active ingredient with wet cellulose is provided, which allows wet cellulose to function as an enteric carrier. "compositions for the systemic treatment of pathological conditions resulting from oxidative stress and / or redox imbalance". Redox homeostasis changes in mammals form the basis of a number of symptoms, syndromes and diseases, including AIDS and cancer, which can be successfully treated by administering to a mammal therapeutically effective amounts of sulfide compounds and / or thiosulfate compounds and / or thionite compounds and / or thionate compounds and / or chemical species which may provide an individual in need thereof with a sulfide compound, thiosulfate compound, thionite compound, or thionate compound. The singular compositions of the present invention contain one or more "active sulfur substances" in combination with each other or with other therapeutic agents. The invention also encompasses variable modes of administration of therapeutic substances. In particular, a new method for combining active ingredients with wet cellulose is provided, whi
